Table 1:

Baseline clinical characteristics of the study population

Total (N = 171)DWI-ASPECTSP Value
7–10 (n = 120)4–6 (n = 51)
Age (yr) (median) (IQR)72 (63.5–78)73 (65–78)68 (60–74).014
Male sex88 (51.5%)58 (48.3%)30 (58.8%).209
Risk factors
    Hypertension95 (55.6%)69 (57.5%)26 (51%).432
    Diabetes mellitus32 (18.7%)22 (18.3%)10 (19.6%).845
    Coronary artery disease20 (11.7%)14 (11.7%)6 (11.8%).985
    Dyslipidemia42 (24.6%)35 (29.2%)7 (13.7%).034a
    Smoking46 (26.9%)27 (22.5%)19 (37.3%).059a
    Atrial fibrillation87 (50.9%)64 (53.3%)23 (45.1%).324
    Congestive heart failure6 (3.5%)5 (4.2%)1 (1.9%).670a
    History of stroke or TIA22 (12.9%)18 (15%)4 (7.8%).317a
Intravenous thrombolysis104 (60.8%)71 (59.2%)33 (64.7%).497
Time to treatment (min) (median) (IQR)245 (190–310)257.5 (190–315)220 (190–281).155
Procedure time (min) (median) (IQR)33 (20–50)34 (20.5–50)30 (20–43.5).444
Time to revascularization (min) (median) (IQR)280 (223.5–352)297.5 (228.5–355)252 (221.5–326).136
Baseline NIHSS score (median) (IQR)13 (10–16)12 (9–15)15 (12–18)<.001
Stroke etiology
    Large-artery atherosclerosis43 (25.1%)32 (26.7%)11 (21.6%).482
    Cardioembolism99 (57.9%)70 (58.3%)29 (56.9%).859
    Undetermined28 (16.4%)17 (14.2%)11 (21.6%).231
  • a Comparisons were performed using the Fisher exact test. Comparisons of categoric variables were performed using χ2 tests unless otherwise indicated.